Atropine sulfate - CAS 55-48-1
Catalog number: 55-48-1
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
2C17H23NO3.H2O4S
Molecular Weight:
676.82
COA:
Inquire
Targets:
mAChR
Description:
Atropine is is a naturally occurring tropane alkaloid extracted from deadly nightshade acts as a competitive muscarinic acetylcholine receptor antagonist.
Purity:
≥98%
Appearance:
White Solid
Synonyms:
(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate;sulfuric acid
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
acetylcholine receptor antagonist.
Quality Standard:
Enterprise Standard/USP/EP
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Melting Point:
192-194°C (lit.)
InChIKey:
HOBWAPHTEJGALG-UHFFFAOYSA-N
InChI:
1S/2C17H23NO3.H2O4S/c2*1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;1-5(2,3)4/h2*2-6,13-16,19H,7-11H2,1H3;(H2,1,2,3,4)
Canonical SMILES:
CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O
1.Activation of M1/4 receptors phase advances the hamster circadian clock during the day.
Basu P1, Wensel AL1, McKibbon R1, Lefebvre N1, Antle MC2. Neurosci Lett. 2016 Apr 7;621:22-27. doi: 10.1016/j.neulet.2016.04.012. [Epub ahead of print]
The mammalian circadian clock in the suprachiasmatic nucleus (SCN) can be reset by the cholinergic agonist carbachol. In hamsters, intraSCN carbachol produces phase advances during the day. This phenomenon has previously been attributed to the muscarinic receptors, as carbachol-induced phase shifts are blocked by pretreatment with the muscarinic antagonist atropine. The SCN contains all five muscarinic receptors, leaving open the question as to which muscarinic receptors mediate these shifts. Here we test two selective muscarinic agonists, the M1/4 agonist McN-A-343 and the M2/3 agonist bethanechol, in addition to the non-selective cholinergic agonist carbachol. Consistent with previous reports, carbachol produced significant phase advances when injected to the SCN during the mid-subjective day. At the doses used here, McN-A-343, but not bethanechol, also produced significant phase shifts when injected to the SCN during the mid-subjective day.
2.The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.
Lochner M1, Thompson AJ2. Neuropharmacology. 2016 Apr 21. pii: S0028-3908(16)30167-8. doi: 10.1016/j.neuropharm.2016.04.027. [Epub ahead of print]
Scopolamine is a high affinity muscarinic antagonist that is used for the prevention of post-operative nausea and vomiting. 5-HT3 receptor antagonists are used for the same purpose and are structurally related to scopolamine. To examine whether 5-HT3 receptors are affected by scopolamine we examined the effects of this drug on the electrophysiological and ligand binding properties of 5-HT3A receptors expressed in Xenopus oocytes and HEK293 cells, respectively. 5-HT3 receptor-responses were reversibly inhibited by scopolamine with an IC50 of 2.09 μM. Competitive antagonism was shown by Schild plot (pA2 = 5.02) and by competition with the 5-HT3 receptor antagonists [3H]granisetron (Ki = 6.76 μM) and G-FL (Ki = 4.90 μM). The related molecule, atropine, similarly inhibited 5-HT evoked responses in oocytes with an IC50 of 1.74 μM, and competed with G-FL with a Ki of 7.94 μM. The reverse experiment revealed that granisetron also competitively bound to muscarinic receptors (Ki = 6.
3.Muscarinic Acetylcholine Receptor-Mediated Stimulation of Retinal Ganglion Cell Photoreceptors.
Sodhi P1, Hartwick AT2. Neuropharmacology. 2016 Apr 4. pii: S0028-3908(16)30128-9. doi: 10.1016/j.neuropharm.2016.04.001. [Epub ahead of print]
Melanopsin-dependent phototransduction in intrinsically photosensitive retinal ganglion cells (ipRGCs) involves a Gq-coupled phospholipase C (PLC) signaling cascade. Acetylcholine, released in the mammalian retina by starburst amacrine cells, can also activate Gq-PLC pathways through certain muscarinic acetylcholine receptors (mAChRs). Using multielectrode array recordings of rat retinas, we demonstrate that robust spiking responses can be evoked in neonatal and adult ipRGCs after bath application of the muscarinic agonist carbachol. The stimulatory action of carbachol on ipRGCs was a direct effect, as confirmed through calcium imaging experiments on isolated ipRGCs in purified cultures. Using flickering (6 Hz) yellow light stimuli at irradiances below the threshold for melanopsin activation, spiking responses could be elicited in ipRGCs that were suppressed by mAChR antagonism. Therefore, this work identified a novel melanopsin-independent pathway for stimulating sustained spiking in ganglion cell photoreceptors.
4.Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer.
Schaefer ES1, Baik C2. Cancer Manag Res. 2016 Mar 24;8:33-8. doi: 10.2147/CMAR.S96471. eCollection 2016.
Anaplastic lymphoma kinase (ALK) gene fusions occur in 3%-7% of non-small-cell lung cancer (NSCLC) cases. Ceritinib, a once-daily, oral ALK inhibitor, has activity against crizotinib-resistant and crizotinib-naïve NSCLC, including brain metastases. Ceritinib (Zykadia™) was granted accelerated approval by the US Food and Drug Administration in 2014 for treating crizotinib-resistant ALK-positive NSCLC. Adverse events (AEs), particularly gastrointestinal (GI) AEs, are commonly experienced at the recommended dose of 750 mg/d and ∼38% of patients require dose interruption or reduction for GI AEs. This case study details our experience with the use of proactive GI AE management regimens in patients treated with ceritinib (750 mg/d) across two study sites. Proactive Regimens A and B were implemented in patients with metastatic ALK-positive NSCLC treated with ceritinib to manage drug-related GI AEs. Regimen A comprised ondansetron and diphenoxylate/atropine or loperamide, taken 30 minutes prior to ceritinib dose.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related mAChR Products


CAS 286930-03-8 Fesoterodine Fumarate

Fesoterodine Fumarate
(CAS: 286930-03-8)

Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor...

CAS 131780-48-8 DAU 5884 hydrochloride

DAU 5884 hydrochloride
(CAS: 131780-48-8)

DAU 5884 hydrochloride is a selective muscarinic M3 receptor antagonist. It inhibits methacholine-dependent effects on cell proliferation and muscle contractili...

ABET
(CAS: 119630-77-2)

Arecaidine But-2-ynyl Ester Tosylate (ABET) is a potent and selective agonist of M2 recceptors in the atrium versus those in the ileum.

CAS 68252-19-7 Pirmenol

Pirmenol
(CAS: 68252-19-7)

Pirmenol, also known as CI-845, a new antiarrhythmic drug, inhibits muscarinic acetylcholine receptor-operated K+ current in the guinea pig heart. However, pirm...

CAS 60-31-1 Acetylcholine Chloride

Acetylcholine Chloride
(CAS: 60-31-1)

Acetylcholine is an organic molecule that acts as a neurotransmitter in many organisms, including humans.

CAS 3854-04-4 Oxotremorine M

Oxotremorine M
(CAS: 3854-04-4)

Oxotremorine is a selective muscarinic acetylcholine receptor agonist. It can be used as a parasympathomimetic drug.

CAS 385367-47-5 Tarafenacin

Tarafenacin
(CAS: 385367-47-5)

Tarafenacin is a highly selective M3 muscarinic receptor antagonist. It was the most potent in inhibiting carbachol-induced bladder contractions of the anti-ch...

CAS 10049-83-9 Pyrithioxin dihydrochloride

Pyrithioxin dihydrochloride
(CAS: 10049-83-9)

Pyrithioxin dihydrochloride, a pyridine thiol derivative, is a nootropic which could be used in the treatment of sequelae of brain trauma, encephalitis and meni...

CAS 242478-38-2 Solifenacin succinate

Solifenacin succinate
(CAS: 242478-38-2)

Solifenacin is a competitive cholinergic receptor antagonist.Solifenacin succinate is a urinary antispasmodic of the antimuscarinic class.

CAS 23062-91-1 PD 102807

PD 102807
(CAS: 23062-91-1)

PD 102807 is a selective mAChR M4 antagonist with IC50 values of 91, 6559, 3441, 95 and 7412 nM for human M4, M1, M2, M3, and M5 receptors respectively.

CAS 65-29-2 Gallamine Triethiodide

Gallamine Triethiodide
(CAS: 65-29-2)

Gallamine Triethiodide is a cholinergic receptor blocker with an IC50 of 68.0 ± 8.4 μM. It is is a non-depolarising muscle relaxant.

CAS 257603-40-0 J 104129 fumarate

J 104129 fumarate
(CAS: 257603-40-0)

The fumarate salt form of J 104129, which has been found to be a muscarinic M3 receptor antagonist with high selectivity.

CAS 77-19-0 Dicycloverine (Dicyclomine)

Dicycloverine (Dicyclomine)
(CAS: 77-19-0)

Dicycloverine, also known as dicyclomine, is an anticholinergic that blocks muscarinic receptors.

CAS 114-49-8 Scopolamine HBr

Scopolamine HBr
(CAS: 114-49-8)

Scopolamine HBr is a competitive muscarinic acetylcholine receptor with an IC50 of 55.3 nM.

CAS 22254-24-6 Ipratropium bromide

Ipratropium bromide
(CAS: 22254-24-6)

Ipratropium bromide, under the trade name Atrovent, structurally similar to atropine, is a muscarinic antagonist and a bronchodilator.

CAS 170105-16-5 Imidafenacin

Imidafenacin
(CAS: 170105-16-5)

Imidafenacin(KRP-197; ONO-8025) is a potent and selective inhibitor of M3 receptors with Kb of 0.317 nM; less potent for M2 receptors(IC50=4.13 nM).

CAS 5892-41-1 Camylofine dihydrochloride

Camylofine dihydrochloride
(CAS: 5892-41-1)

Camylofine dihydrochloride is the salt form of Camylofine. Camylofine is an antimuscarinic with both anticholinergic action as well as direct smooth muscle acti...

CI 969
(CAS: 113590-49-1)

This active molecular is a muscarinic agonist agent.

CAS 3717-88-2 Flavoxate hydrochloride

Flavoxate hydrochloride
(CAS: 3717-88-2)

Flavoxate is an anticholinergic with antimuscarinic effects. Its muscle relaxant properties may be due to a direct action on the smooth muscle rather than by an...

CAS 1160247-92-6 VU 0238429

VU 0238429
(CAS: 1160247-92-6)

VU 0238429 is a selective positive allosteric modulator of M5 muscarinic acetylcholine receptor (EC50 = 1.16, >30 and >30 μM at M5, M1 and M3 receptors, respect...

Chemical Structure

CAS 55-48-1 Atropine sulfate

Quick Inquiry

Verification code

Featured Items